drugset / Trial / NCT01608243
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to investigate the safety of different doses of sublingual tablets of house dust mite allergen extracts in adults with house dust mite-associated allergic asthma.
Timeline
- Start
- 2012-05
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | house dust mite allergen extracts | Unknown | — | Other |